Scholar Rock

Cambridge, United States Founded: 2012 • Age: 14 yrs
Antibody-based drugs for primary myopathies are developed and targeted.
Request Access

About Scholar Rock

Scholar Rock is a company based in Cambridge (United States) founded in 2012.. Scholar Rock has raised $103.3 million across 4 funding rounds from investors including Fidelity Investments, Arch Venture Partners and Invus. The company has 196 employees as of December 31, 2024. Scholar Rock offers products and services including Therapies for Spinal Muscular Atrophy and Therapies for Cancer. Scholar Rock operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.

  • Headquarter Cambridge, United States
  • Employees 196 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Scholar Rock Holding Corporation
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $0
    0
    as on Dec 31, 2024
  • Net Profit
    $-246.29 M
    -48.56
    as on Dec 31, 2024
  • EBITDA
    $-250.12 M
    -48.48
    as on Dec 31, 2024
  • Total Equity Funding
    $103.3 M (USD)

    in 4 rounds

  • Latest Funding Round
    $205 M (USD), Post-IPO

    Jun 17, 2022

  • Investors
  • Employee Count
    196

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Scholar Rock

Scholar Rock is a publicly listed company on the NASDAQ with ticker symbol SRRK in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: SRRK . Sector: Health technology · USA

Products & Services of Scholar Rock

Scholar Rock offers a comprehensive portfolio of products and services, including Therapies for Spinal Muscular Atrophy and Therapies for Cancer. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Investigational treatments targeting growth factors for SMA

Drugs for solid tumors via selective protein inhibition

People of Scholar Rock
Headcount 50-200
Employee Profiles 126
Board Members and Advisors 8
Employee Profiles
People
Ilia A.
Vp, Head Of Global Scientific Communications And Medical Excellence
People
Scott Adamczyk
Senior Vice President, Head Of Regulatory
People
Mohammad Sahtout
Associate Director, Biostatistics
People
Sabrina Lesh, DPT
Clinical Trial Manager II

Unlock access to complete

Board Members and Advisors
people
Srini Akkaraju
Director
people
David Hallal
Chairman
people
Jeffrey Flier
Director
people
Akshay Vaishnaw
Director

Unlock access to complete

Funding Insights of Scholar Rock

Scholar Rock has successfully raised a total of $103.3M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $205 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Post-IPO — $205.0M
  • First Round

    (15 Sep 2014)

  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2022 Amount Post-IPO - Scholar Rock Valuation

investors

Jan, 2018 Amount Series C - Scholar Rock Valuation Invus
Jan, 2016 Amount Series B - Scholar Rock Valuation Fidelity Investments
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Scholar Rock

Scholar Rock has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Fidelity Investments, Arch Venture Partners and Invus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Long-term private equity investments in transformational opportunities are pursued.
Founded Year Domain Location
US focused venture capital firm
Founded Year Domain Location
Venture capital firm focused on life science companies
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Scholar Rock

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Scholar Rock

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Scholar Rock Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Scholar Rock

Scholar Rock operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Drugs for CNS disorders are developed and advanced.
domain founded_year HQ Location
Developer of therapeutic solutions for the treatment of diabetes
domain founded_year HQ Location
Genetically engineered cell therapies are developed for multiple disorders.
domain founded_year HQ Location
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
domain founded_year HQ Location
Therapies for neurological and neuropsychiatric diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Scholar Rock

Frequently Asked Questions about Scholar Rock

When was Scholar Rock founded?

Scholar Rock was founded in 2012 and raised its 1st funding round 2 years after it was founded.

Where is Scholar Rock located?

Scholar Rock is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Who is the current CEO of Scholar Rock?

Nagesh Mahanthappa is the current CEO of Scholar Rock.

Is Scholar Rock a funded company?

Scholar Rock is a funded company, having raised a total of $103.3M across 4 funding rounds to date. The company's 1st funding round was a Series B of $36.3M, raised on Sep 15, 2014.

How many employees does Scholar Rock have?

As of Dec 31, 2024, the latest employee count at Scholar Rock is 196.

What does Scholar Rock do?

Scholar Rock was founded in 2012 in Cambridge, United States, within the biotechnology sector. Niche modulators, a class of biologic therapies, are discovered and developed to selectively target dysregulated growth factors in disease microenvironments, particularly members of the TGFβ superfamily. These therapies address conditions such as fibrosis, musculoskeletal disorders, and autoimmune diseases. Operations focus on antibody-based inhibitors like SRK-015, a monoclonal antibody for latent myostatin activation in primary myopathies.

Who are the top competitors of Scholar Rock?

Scholar Rock's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Biohaven Pharmaceutical.

What products or services does Scholar Rock offer?

Scholar Rock offers Therapies for Spinal Muscular Atrophy and Therapies for Cancer.

Is Scholar Rock publicly traded?

Yes, Scholar Rock is publicly traded on NASDAQ under the ticker symbol SRRK.

Who are Scholar Rock's investors?

Scholar Rock has 8 investors. Key investors include Fidelity Investments, Arch Venture Partners, Invus, Redmile Group, and Polaris Partners.

What is Scholar Rock's ticker symbol?

The ticker symbol of Scholar Rock is SRRK on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available